| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 04/30/1997 | CN1034732C Quinuclidine derivative for treatment of inflammatory and gastrointestinal disorders |
| 04/29/1997 | US5625034 Core antigen protein of hepatitis C virus, and diagnostic method and kit using the same |
| 04/29/1997 | US5624944 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz[cd]indoles |
| 04/29/1997 | US5624941 Pyrazole derivatives, method of preparing them and pharmaceutical compositions in which they are present |
| 04/29/1997 | US5624939 N-acyl pyrrolidines and drugs for the treatment or prevention of cholecystokinin and gastrin-related disorders |
| 04/29/1997 | US5624923 Tricyclic diazepine vasopressin antagonists and oxytocin antagonists |
| 04/29/1997 | US5624672 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof |
| 04/28/1997 | CA2188901A1 Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases |
| 04/27/1997 | CA2188891A1 Use of lanthanide, manganese, tin, zinc or yttrium, cobalt, barium, strontium salt in pharmaceutical compositions |
| 04/24/1997 | WO1997014671A1 Cyclopentyl tachykinin receptor antagonists |
| 04/24/1997 | WO1997011968A3 A gene associated with liver neoplastic disease |
| 04/24/1997 | WO1996038474A3 Diagnosis of, and vaccination against, a positive stranded RNA virus using an isolated, unprocessed polypeptide |
| 04/23/1997 | EP0769300A2 Antiemetic composition containing an NK-1 receptor antagonists |
| 04/23/1997 | EP0769056A1 NON-SPLICING VARIANTS OF gp350/220 |
| 04/23/1997 | EP0769019A1 Helicobacter pylori antigenic protein preparation and immunoassays |
| 04/23/1997 | EP0769018A1 Helicobacter proteins and vaccines |
| 04/23/1997 | EP0768883A1 Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis |
| 04/23/1997 | EP0768874A1 Pharmaceutical compositions containing Triclosan or derivates thereof and Edta or Egta |
| 04/23/1997 | EP0768872A1 New oral pharmaceutical formulation containing magnesium salt of omeprazole |
| 04/23/1997 | EP0626942B1 Bicyclo[2.2.2.]octane derivatives as cholestocystokinin inhibitors |
| 04/23/1997 | CN1148344A New oral pharmaceutical dosage form |
| 04/23/1997 | CN1148340A Method for treating 5HT2B receptor related conditions |
| 04/23/1997 | CN1147942A Antidiarrheal granular for baby pig and method for preparing same |
| 04/23/1997 | CN1034630C Prepn. of composition including binding |
| 04/22/1997 | US5622989 Amino-benzofuryl-and thienyl-derivatives |
| 04/22/1997 | US5622987 Prevent migration or proliferation of smooth muscle cells |
| 04/22/1997 | US5622720 Process for reducing the crystal size of ondansetron hydrochloride dihydrate |
| 04/22/1997 | US5622717 Ulcer prevention method using a melt-spun hydrogel |
| 04/17/1997 | WO1997013844A1 Specific binding members for human transforming growth factor beta; materials and methods |
| 04/17/1997 | WO1997013506A1 η-RAR ANTAGONIST LIGAND OR α-RAR AGONIST LIGAND AS AN APOPTOSIS INHIBITOR |
| 04/17/1997 | WO1997013505A2 USE OF A η-RAR-SPECIFIC AGONIST LIGAND TO INCREASE APOPTOSIS RATE |
| 04/17/1997 | WO1997013501A1 Liposomal compositions and methods of using them |
| 04/17/1997 | WO1997005862A3 Use of basic amino acids and derivatives for lowering ceramide levels |
| 04/17/1997 | DE19545139C1 Use of 1-hydroxy-pyridone cpds. to control yeast and fungi |
| 04/17/1997 | CA2599488A1 Specific binding members for human transforming growth factor beta; materials and methods |
| 04/17/1997 | CA2231561A1 Use of a .gamma.-rar-specific agonist ligand to increase apoptosis rate |
| 04/17/1997 | CA2231547A1 Liposomal compositions and methods of using them |
| 04/17/1997 | CA2187850A1 Physiologically active ei-1941 compounds |
| 04/16/1997 | EP0768375A1 Lactic bacteria |
| 04/16/1997 | EP0768306A1 Physiologically active hydrogenated benzopyran compounds |
| 04/16/1997 | EP0768305A1 N-Isoxazolyl-biphenylsulfonamide derivatives, their preparation and their use as endothelin antagonists |
| 04/16/1997 | EP0768302A2 Hydroxypyridinones |
| 04/16/1997 | EP0768089A1 Health composition |
| 04/16/1997 | EP0767801A1 Endothelin antagonists ii |
| 04/16/1997 | EP0767794A1 Phosphinic acid derivatives |
| 04/16/1997 | EP0767793A1 N-substituted-(dihydroxyboryl)alkyl purine, indole and pyrimidine derivatives, useful as inhibitors of inflammatory cytokines |
| 04/16/1997 | EP0767773A1 Novel antitumor and antileukemia substances, preparation thereof and pharmaceutical compositions containing same |
| 04/16/1997 | EP0625912B1 Treatment for inflammatory bowel disease |
| 04/16/1997 | CN1147767A Use of serotonin antagonists (5HT3) for treating fibromyalgia |
| 04/16/1997 | CN1147403A Medicine powder for stomatopathy and throat disease and its prepn process |
| 04/16/1997 | CN1147398A Chinese patent drug for cirrhosis of liver |
| 04/15/1997 | US5621102 Reacting pinanediol chiral director and haloalkyl dialkoxy metalloid compound to undergo homologation reaction to form intermediate, reacting it with grignard reagent to form secondary alchol, acylating, coupling side chain |
| 04/15/1997 | US5621011 [α-tert.butyl aminomethyl)-3,4-dichlorobenzyl] thioacetamide, a procedure for its preparation and its uses |
| 04/15/1997 | US5620996 Sulfonamidocarbonyl pyridine-2-carboxesteramides and their pyridine-N-oxide compounds and their use as pharmaceuticals |
| 04/15/1997 | US5620995 Substituted heterocyclic carboxyamides, their preparation and their use as pharmaceuticals |
| 04/15/1997 | US5620992 Having 5-hydroxytryptamine receptor antagonist activity |
| 04/15/1997 | US5620990 Alpha-(4-chlorophenyl)-4-[(4-fluorphenyl)-methyl]piperidine-1-ethanol esters, their preparation and their therapeutic application |
| 04/15/1997 | US5620989 4-Arylmethyloxymethyl piperidines as tachykinin antagonsits |
| 04/15/1997 | US5620984 Enatiomerically pure hydroxylated xanthine compounds to treat inflammatory diseases |
| 04/15/1997 | US5620885 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof |
| 04/12/1997 | CA2187576A1 Substituted biphenylsulfonamide endothelin antagonists |
| 04/10/1997 | WO1997012908A1 NOVEL MEMBRANE PROTEINE p76 OF HELICOBACTER PYLORI |
| 04/10/1997 | WO1997012902A1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation |
| 04/10/1997 | WO1997012880A1 Pyrimidine derivatives as 5ht2c-receptor antagonists |
| 04/10/1997 | WO1997012868A1 Quinolone compounds for the treatment of disorders caused by helicobacter pylori |
| 04/10/1997 | WO1997012859A1 Succinimide and maleimide cytokine inhibitors |
| 04/10/1997 | CA2233003A1 Pyrimidine derivatives as 5ht2c-receptor antagonists |
| 04/10/1997 | CA2229785A1 Quinolone compounds for the treatment of disorders caused by helicobacter pylori |
| 04/10/1997 | CA2229434A1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation |
| 04/10/1997 | CA2206708A1 Novel membrane proteine p76 of helicobacter pylori |
| 04/09/1997 | EP0766696A1 Thiazolidine derivatives, their preparation and drugs containing same |
| 04/09/1997 | EP0766695A1 Pyrrolidine derivatives for the treatment of cholecystokinine and gastrine-related disorders |
| 04/09/1997 | EP0766684A1 Endothelin receptor antagonists |
| 04/09/1997 | EP0766680A1 Substituted dihydrobenzofuran derivatives as 5-ht 4 agonists |
| 04/09/1997 | EP0766672A1 Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors |
| 04/09/1997 | EP0766665A2 Metalloproteinase inhibitors |
| 04/09/1997 | EP0766664A2 Metalloproteinase inhibitors |
| 04/09/1997 | EP0766564A1 Controlled release polypeptide compositions and methods of treating inflammatory bowel disease |
| 04/09/1997 | EP0705263B1 Novel carbocyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 04/09/1997 | EP0651739B1 Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 04/09/1997 | EP0638071B1 Heterocyclic carbonic acid derivatives which bind to retinoid receptors (rar) |
| 04/09/1997 | EP0606210B1 Hepatocyte growth stimulation with hepatocyte growth factor and gamma-interferon |
| 04/09/1997 | CN1147260A Neurokinine (tachykinine) antagonists |
| 04/09/1997 | CN1147254A Prodrugs of morpholine tachykinin receptor antagonists |
| 04/09/1997 | CN1147204A Use of spiramycin for treating |
| 04/09/1997 | CN1146910A Chinese medicinal food |
| 04/09/1997 | CN1146908A Chinese medicine preparation for treatment of gastric ulcer, duodenal ulcer and gastritis |
| 04/09/1997 | CN1146903A Prescription of Chinese medicine for treating cholecystitis, cholelithiasis, hepatitis and cholehepatocirrhosis |
| 04/09/1997 | CN1034503C Pyrazolopyrimidinone antianginal agent preparing process |
| 04/09/1997 | CN1034502C Method for preparing N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H benzopyran or dihydrobenzodioxin) carboxamide derivs |
| 04/08/1997 | US5618850 Hydroxy-acid cosmetics |
| 04/08/1997 | US5618844 Matrix metalloproteinase inhibitor |
| 04/08/1997 | US5618834 Indole derivatives in the treatment of emesis |
| 04/08/1997 | US5618833 1-benzyl-1,3-dihydroindol-2-one derivatives, their preparation and the pharmaceutical compositions in which they are present |
| 04/08/1997 | US5618828 Methods for treating gastro-esophageal reflux disease and emesis with optically pure (-) cisapride |
| 04/08/1997 | US5618820 1,3-oxathiolane nucleoside analogues and methods for using same |
| 04/08/1997 | US5618812 Benzodiazepine derivatives |
| 04/08/1997 | US5618811 Gastrointestinal and central nervous system disorders |
| 04/08/1997 | US5618808 Benzothiazepine and benzoxazepine derivatives as cholecystokinin receptor antagonists |
| 04/08/1997 | US5618564 Composition for the treatment of helicobacter pylori infection |